Novel Pathways between Invasiveness Modulators in Breast Cancer Single Cells

Area of Science:

• Molecular biology
• Cancer research
• Cellular heterogeneity

Background:

• Individual cells exhibit distinct behaviors compared to cell populations.
• Understanding proteins controlling cancer invasiveness is crucial for targeted therapies.
• Cellular heterogeneity contributes to differential metastatic potential.

Purpose of the Study:

• To investigate the role of specific proteins in regulating cancer invasiveness at the single-cell level.
• To determine how individual protein knockdown affects matrix metalloproteinase 1 (MMP1) mRNA levels in distinct cancer cell progeny.
• To correlate protein expression changes with metastatic potential in single-cell clones.

Main Methods:

• Utilized Dicer siRNA to perform individual gene knockdown of key proteins (HER4, CDC42, E-cadherin, β-catenin, HER3, PI3K catalytic subunit).
• Quantified MMP1 mRNA levels in two distinct single-cell cancer progeny (SCP2 and SCP21) with differing metastatic potentials.
• Analyzed the impact of specific protein knockdowns on MMP1 expression in each cell line.

Main Results:

• Individual knockdown of HER4, CDC42, and E-cadherin in SCP2 (highly metastatic) decreased MMP1 mRNA levels.
• Individual knockdown of β-catenin, CDC42, HER3, and PI3K catalytic subunit in SCP21 (low metastasis) increased MMP1 mRNA levels.
• Demonstrated differential regulation of MMP1 by specific proteins in cancer cell progeny with varying metastatic capabilities.

Conclusions:

• Single-cell analysis reveals distinct protein functions in regulating cancer invasiveness and metastasis.
• Targeting specific proteins can differentially modulate MMP1 expression and potentially metastatic behavior in cancer subtypes.
• Highlights the importance of considering cellular heterogeneity in developing effective cancer therapies.